REGENXBIO Inc.RGNXNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P46
Within normal range
vs 3Y Ago
-0.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -9.97% |
| Q3 2025 | 17.17% |
| Q2 2025 | -621.79% |
| Q1 2025 | 123.61% |
| Q4 2024 | 17.25% |
| Q3 2024 | -10.78% |
| Q2 2024 | 9.27% |
| Q1 2024 | 3.35% |
| Q4 2023 | 1.63% |
| Q3 2023 | 11.15% |
| Q2 2023 | -10.51% |
| Q1 2023 | -14.52% |
| Q4 2022 | 18.68% |
| Q3 2022 | -13.61% |
| Q2 2022 | 12.57% |
| Q1 2022 | -122.81% |
| Q4 2021 | 646.83% |
| Q3 2021 | -9.81% |
| Q2 2021 | -18.58% |
| Q1 2021 | 17.91% |
| Q4 2020 | -484.57% |
| Q3 2020 | 133.35% |
| Q2 2020 | -10.96% |
| Q1 2020 | 6.51% |
| Q4 2019 | -12.34% |
| Q3 2019 | 2.65% |
| Q2 2019 | -2.69% |
| Q1 2019 | -1565.55% |
| Q4 2018 | 110.78% |
| Q3 2018 | -457.87% |
| Q2 2018 | -93.78% |
| Q1 2018 | 714.68% |
| Q4 2017 | 22.11% |
| Q3 2017 | -41.53% |
| Q2 2017 | 34.32% |
| Q1 2017 | -11.98% |
| Q4 2016 | -9.65% |
| Q3 2016 | -24.85% |
| Q2 2016 | -32.89% |
| Q1 2016 | -104.53% |